Zhibin Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhibin Tan has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Kaavya Narasimhalu
Department of Neurology (SGH Campus), National Neuroscience Institute
3 shared publications - Shih Hui Lim
Department of Neurology, National Neuroscience Institute (Singapore General Hospital Campus), Singapore, Singapore
3 shared publications - Wai Dic Foong
Department of Neurology, National Neuroscience Institute (NNI) @ Singapore General Hospital (SGH), Singapore, Singapore
3 shared publications - You-Jiang Tan
Department of Neurology, National Neuroscience Institute (Singapore General Hospital Campus), Singapore, Singapore
3 shared publications - Anushika Raheja
Department of Neurology National Neuroscience Institute (Singapore General Hospital Campus) Singapore Singapore
2 shared publications - Hua Chan Ling
Department of Neurology, National Neuroscience Institute (Singapore General Hospital Campus), Singapore, Singapore
2 shared publications
Latest Publications
- 23 September 2026
- Published by Elsevier in Epilepsy Research
- Vol. 228
Intrathecal dexamethasone in FIRES
- 23 September 2026
- Published by Elsevier in Epilepsy Research
- Vol. 228
Intrathecal dexamethasone in FIRES
Pharmacogenomics in epilepsy care across Asia
The selection of anti‐seizure medications (ASMs) in epilepsy remains largely empirical, leading to varied efficacy and a significant burden of adverse drug reactions (ADRs). A pharmacogenomic‐based strategy can be used to personalize ASM selection, as it incorporates genetic information into clinical decision‐making. While more than 50 gene–drug associations have been reported in epilepsy, few pairs have strong, replicated evidence with clinical applicability. In Asia, key variants include HLA‐B15:02 and HLA‐A31:01, which are associated with severe cutaneous adverse reactions (SCARs), and CYP2C9 and CYP2C19 variants, which affect drug metabolism. These pairs have influenced regional regulatory policies, with HLA‐B15:02 screening widely implemented prior to carbamazepine use. However, routine practice is still heterogenous due to variability in allele frequencies, healthcare infrastructure, and policy frameworks across countries. We propose evidence‐based criteria for clinical implementation of pharmacogenomic markers, emphasizing replicated associations, clinical significance, actionable alternatives, and cost‐effectiveness. Currently, HLA‐B15:02 possesses the strongest evidence for mandatory screening, while others remain advisory due to limited outcome data. Real‐world challenges include incomplete risk prediction from single‐allele testing, overlapping drug hypersensitivity profiles, and workflow limitations, particularly in urgent care settings. In lower resource regions, test availability and access are additional hurdles to implementation. Future research should include multiethnic datasets, improved health‐economic evaluations, and integration of genomic data into clinical decision‐support systems. Advancing polygenic and multi‐omics approaches could improve prediction of treatment response and toxicity.
Pharmacogenomics in epilepsy care across Asia
The selection of anti‐seizure medications (ASMs) in epilepsy remains largely empirical, leading to varied efficacy and a significant burden of adverse drug reactions (ADRs). A pharmacogenomic‐based strategy can be used to personalize ASM selection, as it incorporates genetic information into clinical decision‐making. While more than 50 gene–drug associations have been reported in epilepsy, few pairs have strong, replicated evidence with clinical applicability. In Asia, key variants include HLA‐B15:02 and HLA‐A31:01, which are associated with severe cutaneous adverse reactions (SCARs), and CYP2C9 and CYP2C19 variants, which affect drug metabolism. These pairs have influenced regional regulatory policies, with HLA‐B15:02 screening widely implemented prior to carbamazepine use. However, routine practice is still heterogenous due to variability in allele frequencies, healthcare infrastructure, and policy frameworks across countries. We propose evidence‐based criteria for clinical implementation of pharmacogenomic markers, emphasizing replicated associations, clinical significance, actionable alternatives, and cost‐effectiveness. Currently, HLA‐B15:02 possesses the strongest evidence for mandatory screening, while others remain advisory due to limited outcome data. Real‐world challenges include incomplete risk prediction from single‐allele testing, overlapping drug hypersensitivity profiles, and workflow limitations, particularly in urgent care settings. In lower resource regions, test availability and access are additional hurdles to implementation. Future research should include multiethnic datasets, improved health‐economic evaluations, and integration of genomic data into clinical decision‐support systems. Advancing polygenic and multi‐omics approaches could improve prediction of treatment response and toxicity.
- Open Access
- 16 January 2026
- Published by Elsevier in Epilepsy Research
- Vol. 220, 107736
Hospitalisation burden among persons with epilepsy attending an outpatient neuroscience specialist clinic in Singapore
- 16 January 2026
- Published by Elsevier in Epilepsy Research
- Vol. 220, 107736
Open AccessHospitalisation burden among persons with epilepsy attending an outpatient neuroscience specialist clinic in Singapore
- Open Access
- 12 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 147
Febrile infection-related epilepsy syndrome (FIRES) in adults: a case report and review of factors associated with survival
Introduction: Febrile infection-related epilepsy syndrome (FIRES) is a subtype of new onset refractory status epilepticus (NORSE) that has, in recent years, been recognized to not only affect pediatric but adult patients too. While inpatient mortality in adult-onset FIRES has been suggested to be higher than in pediatric patients, little is known about the factors associated with survival, hampering research into developing prognostic and stratification models and also posing a challenge for clinical communications and decision making. Methods: We report a fatal case of FIRES in a 21-year-old lady and performed a review of literature involving adult-onset FIRES from 1 Aug 2022 to 17 Aug 2024, analyzing the data to identify factors associated with survival of the initial hospital stay. Results: Including our case, 49 patients of adult-onset FIRES were identified. Of the 47 patients who had MRI brain scan findings described at any time during the illness, 35 patients (74.5%) had abnormal findings in at least one scan, and the most common site of abnormality was the temporal lobe (59.6%). A total of 41 patients survived the initial hospital stay (83.7%). The presence of MRI temporal lobe abnormalities was associated with survival at discharge ( p = 0.013), and the association remained significant on multivariate analysis with corticosteroid usage. Conclusion: In adult-onset FIRES, MRI temporal lobe abnormalities may be associated with survival beyond the acute phase. Our study findings suggest that the site of MRI abnormalities in FIRES may have value in the clinical stratification and prognostication of adult-onset FIRES.
- 12 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 147
Open AccessFebrile infection-related epilepsy syndrome (FIRES) in adults: a case report and review of factors associated with survival
Introduction: Febrile infection-related epilepsy syndrome (FIRES) is a subtype of new onset refractory status epilepticus (NORSE) that has, in recent years, been recognized to not only affect pediatric but adult patients too. While inpatient mortality in adult-onset FIRES has been suggested to be higher than in pediatric patients, little is known about the factors associated with survival, hampering research into developing prognostic and stratification models and also posing a challenge for clinical communications and decision making. Methods: We report a fatal case of FIRES in a 21-year-old lady and performed a review of literature involving adult-onset FIRES from 1 Aug 2022 to 17 Aug 2024, analyzing the data to identify factors associated with survival of the initial hospital stay. Results: Including our case, 49 patients of adult-onset FIRES were identified. Of the 47 patients who had MRI brain scan findings described at any time during the illness, 35 patients (74.5%) had abnormal findings in at least one scan, and the most common site of abnormality was the temporal lobe (59.6%). A total of 41 patients survived the initial hospital stay (83.7%). The presence of MRI temporal lobe abnormalities was associated with survival at discharge ( p = 0.013), and the association remained significant on multivariate analysis with corticosteroid usage. Conclusion: In adult-onset FIRES, MRI temporal lobe abnormalities may be associated with survival beyond the acute phase. Our study findings suggest that the site of MRI abnormalities in FIRES may have value in the clinical stratification and prognostication of adult-onset FIRES.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2026 (1)
Cerebral Edema Secondary to Heavy Metal Toxicity From Siddha Medicine: A Case Report and Case‐Based Review
Background: Traditional Indian medicine has been used to treat a variety of illnesses for centuries. However, there are existing concerns surrounding its heavy metal content. Amongst the different systems of traditional Indian medicine, Ayurvedic medicine has been most frequently implicated in heavy metal toxicity, while Siddha medicine has only very rarely been reported in association with lead and mercury poisoning. Case Presentation: A 58‐year‐old woman presented twice with severe headache, vomiting, dysphasia, truncal ataxia, and tremors. In the second presentation, she also had a clinical seizure. Both times, brain imaging showed diffuse gyral edema, but blood and cerebrospinal fluid tests were unyielding for any explanatory biochemical or serological causes. Both times, the patient displayed clinical and radiologic improvement during her inpatient stay, without any definitive treatment instituted. Eventually, a history of daily Siddha medicine usage for 3 months prior to presentation, as well as in the intervening period between both admissions, was elicited. Blood tests showed high lead levels beyond the assay’s limit for accurate quantification. Pharmaceutical analysis of her Siddha medicine capsules revealed contents of arsenic, mercury, and lead at levels that were several thousand times the safe limits. She was treated with oral dimercaptosuccinic acid with significant improvement in symptoms. Conclusion: We presented an unusual case of generalized cerebral edema caused by multiple metal toxicity from Siddha medicine use. Our case illustrates that Siddha medicine can cause a mixed toxidrome with toxicities from multiple metals at once. Our patient’s highly unusual presenting syndrome, including diffuse cerebral edema on brain imaging and triphasic waves on electroencephalogram, will hopefully be informative for physicians faced with similar cases in future.
- 1 January 2026
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2026 (1)
Open AccessCerebral Edema Secondary to Heavy Metal Toxicity From Siddha Medicine: A Case Report and Case‐Based Review
Background: Traditional Indian medicine has been used to treat a variety of illnesses for centuries. However, there are existing concerns surrounding its heavy metal content. Amongst the different systems of traditional Indian medicine, Ayurvedic medicine has been most frequently implicated in heavy metal toxicity, while Siddha medicine has only very rarely been reported in association with lead and mercury poisoning. Case Presentation: A 58‐year‐old woman presented twice with severe headache, vomiting, dysphasia, truncal ataxia, and tremors. In the second presentation, she also had a clinical seizure. Both times, brain imaging showed diffuse gyral edema, but blood and cerebrospinal fluid tests were unyielding for any explanatory biochemical or serological causes. Both times, the patient displayed clinical and radiologic improvement during her inpatient stay, without any definitive treatment instituted. Eventually, a history of daily Siddha medicine usage for 3 months prior to presentation, as well as in the intervening period between both admissions, was elicited. Blood tests showed high lead levels beyond the assay’s limit for accurate quantification. Pharmaceutical analysis of her Siddha medicine capsules revealed contents of arsenic, mercury, and lead at levels that were several thousand times the safe limits. She was treated with oral dimercaptosuccinic acid with significant improvement in symptoms. Conclusion: We presented an unusual case of generalized cerebral edema caused by multiple metal toxicity from Siddha medicine use. Our case illustrates that Siddha medicine can cause a mixed toxidrome with toxicities from multiple metals at once. Our patient’s highly unusual presenting syndrome, including diffuse cerebral edema on brain imaging and triphasic waves on electroencephalogram, will hopefully be informative for physicians faced with similar cases in future.
- Open Access
- 9 November 2025
- Published by SAGE Publications in Proceedings of Singapore Healthcare
- Vol. 34
Impostor phenomenon in neurology trainees peaks at commencement of residency
Background: Impostor phenomenon, characterised by self-perceived incompetence and inadequacy, has adverse effects on career progression and psychological wellbeing. While it is prevalent in various medical specialties, its prevalence in neurology is unknown. Methods: Anonymous surveys were conducted among neurology trainees and junior neurologists over two windows across two major campuses in Singapore. The first window recruited incoming neurology residents (R0). The second window recruited neurology residents enrolled in any year of training (R1, R2, and R3) and junior neurologists (specialists practising within the first 2 years of accreditation). The second window included the same respondents from the first window. The Leary Impostorism Scale (LIS) was used, with a score of 15 indicating moderate or severe impostorism. Results: The first window recorded five out of a possible five responses. The second window recorded 14 out of a possible 23 responses. The median LIS score started at 21 (interquartile range, IQR 15-25) among R0 residents, peaked at 28 (IQR 22-28) among R1 neurology residents, before declining to 15.5 (IQR 14-16.3) among R2 residents and 11 (IQR 10-16) among junior neurologists. No responses were received from R3 residents. There was a significant difference between the median LIS scores of each level of training (Kruskal-Wallis H = 10.398, p = 0.015). 10 out of 14 respondents (71.4%) had moderate or severe impostorism. Conclusions: Impostor phenomenon is pervasive among neurology trainees and junior neurologists. Further studies are needed to investigate the impact of impostor phenomenon on neurology trainees and to identify means of mitigating it.
- 9 November 2025
- Published by SAGE Publications in Proceedings of Singapore Healthcare
- Vol. 34
Open AccessImpostor phenomenon in neurology trainees peaks at commencement of residency
Background: Impostor phenomenon, characterised by self-perceived incompetence and inadequacy, has adverse effects on career progression and psychological wellbeing. While it is prevalent in various medical specialties, its prevalence in neurology is unknown. Methods: Anonymous surveys were conducted among neurology trainees and junior neurologists over two windows across two major campuses in Singapore. The first window recruited incoming neurology residents (R0). The second window recruited neurology residents enrolled in any year of training (R1, R2, and R3) and junior neurologists (specialists practising within the first 2 years of accreditation). The second window included the same respondents from the first window. The Leary Impostorism Scale (LIS) was used, with a score of 15 indicating moderate or severe impostorism. Results: The first window recorded five out of a possible five responses. The second window recorded 14 out of a possible 23 responses. The median LIS score started at 21 (interquartile range, IQR 15-25) among R0 residents, peaked at 28 (IQR 22-28) among R1 neurology residents, before declining to 15.5 (IQR 14-16.3) among R2 residents and 11 (IQR 10-16) among junior neurologists. No responses were received from R3 residents. There was a significant difference between the median LIS scores of each level of training (Kruskal-Wallis H = 10.398, p = 0.015). 10 out of 14 respondents (71.4%) had moderate or severe impostorism. Conclusions: Impostor phenomenon is pervasive among neurology trainees and junior neurologists. Further studies are needed to investigate the impact of impostor phenomenon on neurology trainees and to identify means of mitigating it.
- Open Access
- 22 August 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (5) , 1630-1638
Why patients say no: Patient barriers to epilepsy surgery among patients with drug‐resistant epilepsy in Singapore
Objective: Epilepsy surgery is globally underutilized due to disease‐, system‐, and patient‐related barriers. These barriers are suboptimally understood in Asia. Patient‐related barriers are of particular interest because they are culture‐specific and may present a significant obstacle regardless of resource availability. This study aims to identify patient‐related barriers in Singapore, an ethnically heterogeneous Asian country. Methods: We conducted a cross‐sectional survey of focal drug‐resistant epilepsy (DRE) patients attending the neurology specialist outpatient clinic of a major tertiary hospital in Singapore. The survey contained 28 items assessing patient perceptions of epilepsy and its treatment, and 7 items on the patient's socioeconomic status. It was adapted with permission from a previous Canadian study. Results: A total of 66 patients completed the survey. Most patients (74.2%) were aware of surgery as an option for the treatment of epilepsy, and patients with university degrees were more likely to be aware ( p = 0.007). Most (69.7%) viewed surgery as a “last resort,” and 83.3% overestimated the risks of surgery. Even when hypothetically offered guarantees of surgical success, only 57.6% of patients responded favorably to surgery, with those acknowledging their seizures as disabling being more likely to respond favorably ( p = 0.027). Financial considerations did not significantly influence reactions to hypothetically successful surgery ( p = 1.000). Significance: There are major patient‐related barriers to epilepsy surgery among DRE patients in Singapore, contributed by an overestimation of surgical risks and an indifference to seizure‐related disability in some patients. Based on our findings, financial subsidies alone may not suffice in addressing patient‐related barriers; accompanying patient education efforts may be important. Plain Language Summary: A survey of patients with refractory epilepsy in Singapore revealed that patients are relatively averse to undergoing pre‐surgical evaluation and surgical treatment for epilepsy, despite scientific evidence of effectiveness. Some of the major barriers include patients overestimating the risks of epilepsy surgery and perceiving seizures to be non‐disabling. Our findings suggest that financial subsidies for surgery alone may not overcome patients' aversion to surgery, and that patient education is also required.
- 22 August 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (5) , 1630-1638
Open AccessWhy patients say no: Patient barriers to epilepsy surgery among patients with drug‐resistant epilepsy in Singapore
Objective: Epilepsy surgery is globally underutilized due to disease‐, system‐, and patient‐related barriers. These barriers are suboptimally understood in Asia. Patient‐related barriers are of particular interest because they are culture‐specific and may present a significant obstacle regardless of resource availability. This study aims to identify patient‐related barriers in Singapore, an ethnically heterogeneous Asian country. Methods: We conducted a cross‐sectional survey of focal drug‐resistant epilepsy (DRE) patients attending the neurology specialist outpatient clinic of a major tertiary hospital in Singapore. The survey contained 28 items assessing patient perceptions of epilepsy and its treatment, and 7 items on the patient's socioeconomic status. It was adapted with permission from a previous Canadian study. Results: A total of 66 patients completed the survey. Most patients (74.2%) were aware of surgery as an option for the treatment of epilepsy, and patients with university degrees were more likely to be aware ( p = 0.007). Most (69.7%) viewed surgery as a “last resort,” and 83.3% overestimated the risks of surgery. Even when hypothetically offered guarantees of surgical success, only 57.6% of patients responded favorably to surgery, with those acknowledging their seizures as disabling being more likely to respond favorably ( p = 0.027). Financial considerations did not significantly influence reactions to hypothetically successful surgery ( p = 1.000). Significance: There are major patient‐related barriers to epilepsy surgery among DRE patients in Singapore, contributed by an overestimation of surgical risks and an indifference to seizure‐related disability in some patients. Based on our findings, financial subsidies alone may not suffice in addressing patient‐related barriers; accompanying patient education efforts may be important. Plain Language Summary: A survey of patients with refractory epilepsy in Singapore revealed that patients are relatively averse to undergoing pre‐surgical evaluation and surgical treatment for epilepsy, despite scientific evidence of effectiveness. Some of the major barriers include patients overestimating the risks of epilepsy surgery and perceiving seizures to be non‐disabling. Our findings suggest that financial subsidies for surgery alone may not overcome patients' aversion to surgery, and that patient education is also required.
- 8 August 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (12) , 5859-5874
Acute hemorrhagic leukoencephalitis: a case report and systematic review of factors associated with severe disability and death
Introduction Acute hemorrhagic leukoencephalitis (AHLE), a rare form of acute disseminated encephalomyelitis (ADEM), has a generally poor prognosis. However, significant variation is observed, and even complete recovery has been reported. The recent increase in the frequency of AHLE case reports is possibly contributed by the advent of COVID-19 and may have added to the heterogeneity of cases. Methods We report a fatal case of AHLE with a preceding unspecified respiratory infection, then perform a systematic review of AHLE, in an effort to delineate factors that may be associated with an ultimate outcome of severe disability (defined as modified Rankin scale score of 4 or 5) or death. Results Descriptions of 31 cases of AHLE were found in 21 identified articles, with our case being the 32nd case. The most common antecedent event was an infection (20 patients, 62.5%), with nearly half of these being COVID-19 (9 patients). The majority of patients had a subacute progression (1 to 10 days) from onset to clinical nadir. We found that an altered mental status (AMS) and a Glasgow Coma Scale (GCS) score of less than 12 were associated with a final outcome of severe disability or death. An abnormal upgoing plantar response was associated with a final outcome of death. COVID-19 and its vaccines were not associated with either outcome. Conclusion AMS, depressed GCS, and an upgoing plantar response at presentation may be associated with a poor outcome in AHLE. Our findings may serve as a springboard to much-needed research into the stratification of AHLE.
- 8 August 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (12) , 5859-5874
Acute hemorrhagic leukoencephalitis: a case report and systematic review of factors associated with severe disability and death
Introduction Acute hemorrhagic leukoencephalitis (AHLE), a rare form of acute disseminated encephalomyelitis (ADEM), has a generally poor prognosis. However, significant variation is observed, and even complete recovery has been reported. The recent increase in the frequency of AHLE case reports is possibly contributed by the advent of COVID-19 and may have added to the heterogeneity of cases. Methods We report a fatal case of AHLE with a preceding unspecified respiratory infection, then perform a systematic review of AHLE, in an effort to delineate factors that may be associated with an ultimate outcome of severe disability (defined as modified Rankin scale score of 4 or 5) or death. Results Descriptions of 31 cases of AHLE were found in 21 identified articles, with our case being the 32nd case. The most common antecedent event was an infection (20 patients, 62.5%), with nearly half of these being COVID-19 (9 patients). The majority of patients had a subacute progression (1 to 10 days) from onset to clinical nadir. We found that an altered mental status (AMS) and a Glasgow Coma Scale (GCS) score of less than 12 were associated with a final outcome of severe disability or death. An abnormal upgoing plantar response was associated with a final outcome of death. COVID-19 and its vaccines were not associated with either outcome. Conclusion AMS, depressed GCS, and an upgoing plantar response at presentation may be associated with a poor outcome in AHLE. Our findings may serve as a springboard to much-needed research into the stratification of AHLE.
- Open Access
- 4 June 2024
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 3
Comparison of Simultaneously Performed Transcranial Doppler and Transthoracic Echocardiogram in Patients with Suspected Patent Foramen Ovale
Background: Patent foramen ovale (PFO) is a distinctive aetiology of cryptogenic stroke. The established benchmark for diagnosing PFO is the transoesophageal echocardiography with agitated saline or ‘bubble’ (TOE-b) study. Transcranial Doppler with bubble (TCD-b) or transthoracic echocardiography with bubble (TTE-b) examinations are common initial screening tests for PFO. However, the degree of concordance and discordance between the results of these two approaches remain unclear. Methods: In this prospective observational study, individuals presenting with suspected PFO-associated stroke between 2018 and 2021 underwent simultaneous TCD-b and TTE-b examinations within a joint neuro-cardiovascular laboratory to assess rates of concordance and discordance between TCD-b and TTE-b results. Additionally, data from any subsequent TOE-b studies were gathered. Results: Twenty-two patients were included. Ten patients (45%) exhibited concordantly negative findings and seven patients (32%) had concordantly positive results. Discordant outcomes were recorded in five patients (23%). Subsequently, a subset of seven patients (32%) underwent TOE-b, which confirmed the presence of right-to-left shunts. Among these cases, TCD-b consistently and accurately identified right-to-left shunts in all instances. In contrast, four out of these seven cases exhibited negative TTE-b results. Conclusion: This study indicates that there is significant discordance between TCD-b and TTE-b results (five of 22; 23%). Additionally, the results suggest that TCD-b might be a more effective screening test for detecting PFO compared with TTE-b.
- 4 June 2024
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 3
Open AccessComparison of Simultaneously Performed Transcranial Doppler and Transthoracic Echocardiogram in Patients with Suspected Patent Foramen Ovale
Background: Patent foramen ovale (PFO) is a distinctive aetiology of cryptogenic stroke. The established benchmark for diagnosing PFO is the transoesophageal echocardiography with agitated saline or ‘bubble’ (TOE-b) study. Transcranial Doppler with bubble (TCD-b) or transthoracic echocardiography with bubble (TTE-b) examinations are common initial screening tests for PFO. However, the degree of concordance and discordance between the results of these two approaches remain unclear. Methods: In this prospective observational study, individuals presenting with suspected PFO-associated stroke between 2018 and 2021 underwent simultaneous TCD-b and TTE-b examinations within a joint neuro-cardiovascular laboratory to assess rates of concordance and discordance between TCD-b and TTE-b results. Additionally, data from any subsequent TOE-b studies were gathered. Results: Twenty-two patients were included. Ten patients (45%) exhibited concordantly negative findings and seven patients (32%) had concordantly positive results. Discordant outcomes were recorded in five patients (23%). Subsequently, a subset of seven patients (32%) underwent TOE-b, which confirmed the presence of right-to-left shunts. Among these cases, TCD-b consistently and accurately identified right-to-left shunts in all instances. In contrast, four out of these seven cases exhibited negative TTE-b results. Conclusion: This study indicates that there is significant discordance between TCD-b and TTE-b results (five of 22; 23%). Additionally, the results suggest that TCD-b might be a more effective screening test for detecting PFO compared with TTE-b.
- Open Access
- 14 May 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (5) , e8932
Extraordinary linear non‐enhancing brainstem leptomeningeal metastasis from lung adenocarcinoma: A case report
Key Clinical Message: In patients with lung adenocarcinoma, angiogenesis‐altering drugs can alter the appearance of leptomeningeal metastasis on magnetic resonance imaging (MRI) scans. In the ventral brainstem, this can manifest as a unique, linear, non‐enhancing T2‐hyperintense signal.
- 14 May 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (5) , e8932
Open AccessExtraordinary linear non‐enhancing brainstem leptomeningeal metastasis from lung adenocarcinoma: A case report
Key Clinical Message: In patients with lung adenocarcinoma, angiogenesis‐altering drugs can alter the appearance of leptomeningeal metastasis on magnetic resonance imaging (MRI) scans. In the ventral brainstem, this can manifest as a unique, linear, non‐enhancing T2‐hyperintense signal.